Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266

Watchlist Manager
Suzhou Zelgen Biopharmaceuticals Co Ltd Logo
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Watchlist
Price: 67.99 CNY -0.89%
Market Cap: 18B CNY
Have any thoughts about
Suzhou Zelgen Biopharmaceuticals Co Ltd?
Write Note

Suzhou Zelgen Biopharmaceuticals Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Suzhou Zelgen Biopharmaceuticals Co Ltd
Cash Paid for Dividends Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Cash Paid for Dividends Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Cash Paid for Dividends
-ÂĄ21.2m
CAGR 3-Years
-167%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Paid for Dividends
-ÂĄ141.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Paid for Dividends
-ÂĄ907.5m
CAGR 3-Years
-711%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash Paid for Dividends
-ÂĄ247.2m
CAGR 3-Years
-2%
CAGR 5-Years
-39%
CAGR 10-Years
-12%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Paid for Dividends
-ÂĄ104.4m
CAGR 3-Years
52%
CAGR 5-Years
34%
CAGR 10-Years
-3%
Imeik Technology Development Co Ltd
SZSE:300896
Cash Paid for Dividends
-ÂĄ1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-21.2m CNY

Based on the financial report for Dec 31, 2023, Suzhou Zelgen Biopharmaceuticals Co Ltd's Cash Paid for Dividends amounts to -21.2m CNY.

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 3Y
-167%

Over the last year, the Cash Paid for Dividends growth was -89%. The average annual Cash Paid for Dividends growth rates for Suzhou Zelgen Biopharmaceuticals Co Ltd have been -167% over the past three years .

Back to Top